CAR-T Cell Therapy in China


Beijing Bioocus International Medical Center in Beijing, China


Sign in with google


Beijing Biofocus International Medical Center (BBIMC) is a leading provider of cellular immunotherapy in China, with a particular focus on CAR-T therapy. As a pioneer in this innovative cancer treatment, BBIMC has been instrumental in bringing this cutting-edge technology to patients in China.

The center boasts a team of experienced oncologists and hematologists who specialize in CAR-T therapy. They work closely with patients to develop personalized treatment plans that are tailored to their individual needs and medical conditions. BBIMC’s state-of-the-art facilities and advanced technologies enable them to deliver high-quality CAR-T therapy in a safe and controlled environment.

BBIMC is committed to providing comprehensive care for patients undergoing CAR-T therapy. This includes pre-treatment evaluations, T-cell collection and modification, infusion of CAR-T cells, and post-treatment monitoring. The center also offers supportive care services to help patients manage any potential side effects of the therapy.

Treatment Approaches​

CAR-T Cell Therapy

Stem Cell Therapy

NK Cell Therapy

Tills Cell Theray

Benefits of CAR-T Cell Therapy

Targeted Therapy

CAR-T cell therapy is highly targeted. It engineers a patient’s own immune cells to specifically recognize and attack cancer cells, sparing healthy cells from damage. This targeted approach can lead to more effective treatment with fewer side effects compared to traditional chemotherapy.

High Response Rates

Clinical trials have shown high response rates with CAR-T cell therapy in patients with certain types of blood cancers, including those who have not responded to other treatments or have relapsed after previous therapies. Some patients experience complete remission, meaning no detectable cancer cells remain.

Potential for Long-lasting Effects

CAR-T cell therapy has the potential for long-lasting effects, with some patients remaining in remission for years after treatment. This durability is a significant advantage, especially considering that many other cancer treatments may only provide temporary benefits.

Personalized Treatment

CAR-T cell therapy involves engineering a patient’s own immune cells to target their specific cancer cells. This personalized approach holds promise for treating each patient’s cancer more effectively, potentially leading to better outcomes compared to one-size-fits-all treatments.

Fewer Side Effects

While CAR T-cell therapy can cause side effects, such as cytokine release syndrome (CRS) and neurotoxicity, these are generally less severe and less frequent than those associated with traditional chemotherapy.


CAR-T cell therapy, a revolutionary cancer treatment, has gained recognition for its remarkable success rates. However, its widespread adoption has often been hindered by the high costs associated with the therapy in many parts of the world. Beijing Bioocus International Medical Center is changing this narrative by offering CAR-T cell therapy at a significantly more affordable price range of $100,000 to $150,000.

This cost-effective approach makes CAR-T cell therapy accessible to a wider range of patients, both domestic and international, seeking advanced cancer care in China. Despite the reduced cost, Beijing Bioocus maintains rigorous treatment standards and provides comprehensive medical services throughout the entire treatment journey, ensuring patients receive the highest quality care.


Cost in USD

CAR-T Cell Therapy

$100,000 - $150,000

Dr. Daopei Lu

Dr. Daopei Lu is a very important scientist in China. He studies stem cells, which are very tiny things in our bodies that can turn into different kinds of cells. Dr. Lu works as the top scientist at a company called Beijing Bioocus Biotech Limited. He has been working in this field for many years and has done a lot of important things. He is famous not just in China but also in other countries.

Dr. Lu has done many important things in his career. He helped start a special place for studying blood diseases at Peking University. He also teaches at other big universities in China. He has been part of groups that make important decisions about medicine in China. Dr. Lu has also won many awards for his work. He has helped many people and has made a big difference in how we understand and treat diseases.

Frequently Asked Questions

In CAR-T cell therapy, T cells are extracted from a patient’s blood and modified in a laboratory to express chimeric antigen receptors (CARs) on their surface. These CARs enable the T cells to recognize specific proteins (antigens) on cancer cells. Once infused back into the patient, the CAR-T cells can target and kill cancer cells bearing the target antigen.

CAR-T cell therapy has been primarily used to treat certain types of blood cancers, such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and certain types of non-Hodgkin lymphoma (NHL).

CAR-T cell therapy has shown remarkable effectiveness, especially in patients with certain types of blood cancers that have not responded to standard treatments. Many patients who receive CAR-T cell therapy experience complete remission, although the durability of these responses varies among individuals.

The entire process of CAR-T cell therapy, from T cell collection to infusion, typically takes several weeks. This includes the time required for T cell collection, genetic modification in the laboratory, patient preparation (which may involve chemotherapy), and monitoring for potential side effects after CAR-T cell infusion.

During the infusion of CAR-T cells, the modified T cells are administered to the patient intravenously, similar to a blood transfusion. The process usually takes several hours and is performed in a specialized healthcare setting equipped to manage potential side effects.

Location Overview

Beijing, China, stands as a premier destination for medical tourism, epitomizing excellence in healthcare delivery within a rich cultural tapestry. Renowned for its world-class medical facilities, Beijing attracts a diverse array of international patients seeking advanced treatment options across various medical specialties, including oncology

Advanced Medical Facilities

Beijing is home to some of the most advanced medical facilities in Asia, equipped with state-of-the-art technology and infrastructure for cancer diagnosis, treatment, and research.

Specialized Cancer Centers

Beijing boasts specialized cancer centers and hospitals renowned for their expertise in oncology. These centers often have multidisciplinary teams of oncologists, surgeons, radiologists, and support staff dedicated to providing comprehensive cancer care.

Access to Cutting-Edge Treatments

Beijing offers access to cutting-edge cancer treatments, including innovative therapies such as CAR-T cell therapy, targeted therapies, immunotherapy, and precision medicine approaches. Clinical trials for experimental cancer treatments may also be available in Beijing.

Experienced Oncologists

Beijing attracts top oncologists and cancer specialists from around the world, many of whom have extensive experience in treating various types of cancer. Patients can benefit from the expertise and personalized care provided by these healthcare professionals.


Compared to Western countries, cancer treatment costs in Beijing and other parts of China may be more affordable for international patients. This includes not only the cost of medical procedures but also accommodations and other associated expenses.

How Can We Help You?

Ready to explore CAR-T cell therapy at Beijing Bioocus International Medical Center? Reach out today to start your journey towards cutting-edge cancer treatment in China. Contact us now and see how we can make this happen for you!